Curated News:

NEJM

Add to Favorites Subscribe Share
fbshare-NEJM

Showing results

110 of 363
Jefferson4CHP3002.jpg
Released:
11-Dec-2019 9:50 AM EST
Newswise: Head-to-Head Comparison Finds Three Anti-Seizure Drugs Equally Effective for Severe Form of Epilepsy
  • Embargo expired:
    27-Nov-2019 5:05 PM EST
Released:
27-Nov-2019 10:30 AM EST
Research Results
Newswise: Better way to interpret blood tests to diagnose pulmonary embolism
  • Embargo expired:
    27-Nov-2019 5:00 PM EST

Better way to interpret blood tests to diagnose pulmonary embolism

McMaster University

A study led by Hamilton researchers has found a new way to interpret blood test results in patients who are investigated for blood clots in their lungs, a condition known as pulmonary embolism. This new approach applies to D-dimer blood tests, which are used by physicians to rule out the presence of a blood clot.

Channels: All Journal News, Blood, Healthcare, Respiratory Diseases and Disorders, NEJM,

Released:
25-Nov-2019 11:45 AM EST
Research Results
Newswise: Secondary surgery does not improve overall survival for recurrent ovarian cancer patients
  • Embargo expired:
    13-Nov-2019 5:00 PM EST

Secondary surgery does not improve overall survival for recurrent ovarian cancer patients

University of Texas M. D. Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center reported that secondary tumor-reduction, or cytoreduction, surgery followed by chemotherapy did not result in longer survival than chemotherapy alone in patients with platinum-sensitive recurrent ovarian cancer.

Channels: All Journal News, Cancer, Surgery, Women's Health, NEJM,

Released:
12-Nov-2019 10:00 AM EST
Research Results

Three-drug combo improves lung function in most common genetic form of cystic fibrosis

UT Southwestern Medical Center

A phase three clinical trial that UT Southwestern participated in determined that a three-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common genetic mutation for the disease.

Channels: All Journal News, Children's Health, Clinical Trials, Digestive Disorders, Genetics, Pharmaceuticals, Respiratory Diseases and Disorders, NEJM,

Released:
31-Oct-2019 4:55 PM EDT
Research Results
mmc-logo.gif

Mayo Clinic studies patient privacy in MRI research

Mayo Clinic

Though identifying data typically are removed from medical image files before they are shared for research, a Mayo Clinic study finds that this may not be enough to protect patient privacy.

Channels: All Journal News, Patient Safety, Technology, National Institutes of Health (NIH), NEJM,

Released:
23-Oct-2019 5:00 PM EDT
Research Results
color-without-R-core-standard.png

Beta-blocker trial does not reduce risks for COPD patients

University of Alabama at Birmingham

Dransfield said their findings showed no evidence that beta-blockers were helpful in reducing the risk of exacerbations.

Channels: All Journal News, Cardiovascular Health, Heart Disease, Respiratory Diseases and Disorders, NEJM,

Released:
21-Oct-2019 10:05 AM EDT
Research Results
baylorscottandwhite.jpg

New Research Could Change Clinical Practice for Cases of Unmanaged Heartburn

Baylor Scott and White Health

A study published today in The New England Journal of Medicine found that in patients seen for heartburn unresponsive to treatment with Proton Pump Inhibitors (PPIs), an extensive, systematic workup revealed truly PPI-refractory and reflux-related heartburn in only a minority of cases. In other words, most patients with heartburn unrelieved by PPIs did not have gastroesophageal reflux disease (GERD) causing the symptom. Furthermore, for the selected subgroup identified as having reflux-related, PPI-refractory heartburn, surgery that corrects reflux was significantly superior (67% success rate) to continued medical therapy (28% success rate).

Channels: All Journal News, Clinical Trials, Digestive Disorders, Surgery, NEJM,

Released:
17-Oct-2019 7:00 AM EDT
Research Results
JOS-logo.gif

Artificial pancreas system better controls blood glucose levels than current technology

Joslin Diabetes Center

A multi-center randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — has found that the new system was more effective than existing treatments at controlling blood glucose levels in people with type 1 diabetes.The study showed that the system improved participants’ blood glucose control throughout the day and overnight.

Channels: All Journal News, Clinical Trials, Diabetes, Digestive Disorders, Kidney Disease, NEJM,

Released:
16-Oct-2019 8:05 PM EDT
Research Results

Showing results

110 of 363

Chat now!
2.75285